Northrop Grumman Reports Strong Q4 & Full-Year 2025 Results, Record Backlog, and Positive 2026 Guidance
NOC sits 55% above its 52-week low of $426.24.
Summary
Northrop Grumman announced strong Q4 and full-year 2025 financial results, including increased sales, record backlog, and robust free cash flow, alongside positive guidance for 2026.
Key Events · Earnings and Guidance · NOC
-
Strong Q4 and Full-Year 2025 Financial Performance
Fourth quarter 2025 sales increased 10% to $11.7 billion, while full-year sales grew 2% to $42.0 billion. Diluted EPS for Q4 was $9.99 and for the full year was $29.08, with MTM-adjusted EPS at $7.23 and $26.34 respectively.
-
Record Backlog and Strong Book-to-Bill
The company achieved a new record backlog of $95.7 billion, driven by a full-year book-to-bill ratio of 1.10, signaling strong future contract awards and revenue potential.
-
Robust Free Cash Flow Generation
Northrop Grumman reported strong operating cash flow of $4.8 billion and free cash flow of $3.3 billion for the full year 2025, representing a 26% increase in free cash flow year-over-year.
-
Positive 2026 Financial Guidance
The company provided 2026 guidance projecting mid-single digit sales growth, with anticipated sales between $43.5 billion and $44.0 billion, and MTM-adjusted EPS between $27.40 and $27.90, consistent with prior outlook.
Analysis · NOC · Manufacturing
Northrop Grumman delivered robust financial results for the fourth quarter and full-year 2025, exceeding expectations with significant sales growth and strong free cash flow. The company achieved a new record backlog of $95.7 billion, supported by a healthy book-to-bill ratio of 1.10, indicating strong future revenue visibility. The positive momentum is projected to continue into 2026, with guidance forecasting mid-single digit sales growth and sustained strong performance, reinforcing investor confidence in the company's operational strength and market position.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NOC was trading at $661.04 on NYSE in the Manufacturing sector, with a market capitalization of approximately $94.3B. The 52-week trading range was $426.24 to $677.30. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.